Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Canadian Pharmaceutical Agency Wants Ban on Exports to U.S.
The Canadian National Association of Pharmacy Regulatory Authorities (NAPRA), Canada's voluntary umbrella association of provincial and territorial pharmacy licensing bodies, has asked the Canadian government to legislate against the export of drug products to the United States. In a press release issued by NAPRA November 13, the organization noted that such exports are creating a challenge for those pledged to protecting Canadian public safety, and placed much of the blame for the problem on American agencies' failure to enforce U.S. laws. “The [Canadian] federal and provincial regulatory systems … were not originally designed to regulate the export of prescription drugs. Provincial self-regulation of the profession of pharmacy and the distribution of drugs is intended to protect Canadians. Similarly, the federal drug approval process is designed so that Canadians will have safe and effective access to drugs,” the release stated.
NAPRA criticized other, unnamed, Canadian government agencies – presumably governmental bodies in those provinces that are taking the greatest advantage of the demand – that encourage the export of drugs to other countries for the purpose of increasing regional economic growth. This practice, NAPRA claims, conflicts with the national public policy of providing Canadians with access to pharmaceutical products. NAPRA's statement warns that because of the conflict resulting from these competing objectives, those government agencies responsible for promoting export of Canadian drugs in order to boost local economies “must also be responsible for the consequences.” These consequences so far have included moves by pharmaceutical companies to raise prices in Canada, as well as to cut off or limit sales to Canadian pharmaceutical distributors.
Why So Many Great Lawyers Stink at Business Development and What Law Firms Are Doing About It
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
A Lawyer's System for Active Reading
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
Protecting Innovation in the Cyber World from Patent Trolls
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.